Cristina Gavina is an expert in Cardiology at Hospital Pedro Hispano (Portugal). Cristina Gavina has authored 131 publications, the most recent in 2026, and is an investigator in 10 clinical trials, 2 of them ongoing. SLR score: 654 (community average: 125). How the SLR is computed.

LeadR Profile

Cristina Gavina Hospital Pedro Hispano Portugal
654 ScienceLeadR Reputation 654
Network Map

Cardiology

Subspecialties: Public Health - Internal Medicine - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2006 - 2026

Source: PubMed

Hospital Pedro Hispano

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 131

Citations

Citations: 15 485 1st author: 24 Last author: 19 Unique author: 7


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Sex Differences in Heart Failure Treatment: A Signal Worth Pursuing?
PMID 42904310 — heart failure, heart, treatment failure, sex characteristics, sex, therapeutics, sex differences
Eur J Heart Fail20260
Community Pharmacy Involvement in Cardiovascular Patient Follow-Up: A Conceptual Framework for Integrated Ambulatory Pharmaceutical Care.
PMID 42881591 — heart failure, pharmaceutical preparations, heart, cardiac rehabilitation, cardiovascular diseases, pharmacists, continuity of patient care, pharmacy, rehabilitation, drug therapy, risk management, risk factors, ambulatory care, therapeutics, heart disease risk factors
Healthcare (Basel)20260
Translating Guidelines into Practice: Implementation of NT-proBNP Testing for Early Heart Failure Detection in Diabetes, a Narrative Review.
PMID 42711516 — diabetes mellitus, research design, interdisciplinary communication, heart failure, internal medicine, heart, translating, biomarkers
J Gen Intern Med20260
2026 ESC Guidelines for the management of cardiovascular disease and chronic kidney disease, in collaboration with the European Renal Association (ERA).
PMID 42661426 — kidney diseases, cardiovascular diseases, kidney, cardiology
Eur Heart J Top journal20262
The Unfulfilled Promise of Potassium Binding in Heart Failure With Reduced Ejection Fraction.
PMID 42615956 — hyperkalemia, heart failure, heart, cardiology, heart failure, systolic
J Am Coll Cardiol20260

Clinical Studies 10

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 10

By status:

Completed 6
Active not recruiting 1
Recruiting 1
Terminated 1
Unknown 1

By type:

Interventional 10

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 8

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A randomized double blind placebo controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovascular events in high risk primary prevention patients (VICTORION 1 PREVENT)
2022-502779-40-00 — cardiovascular diseases, primary prevention
Phase 3Active not recruiting2023
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME CV)
2024-516652-18-00 — cardiovascular diseases, obesity, therapeutics, overweight
Phase 3Recruiting2025

LeadR Networks

Main global connection map